SMOC2:

Xin Chen1,2,3, Xing Zhong1,4, Dan Luo1,2,3

  • 1Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei Province, People's Republic of China.

概括

在心力衰竭 (HF) 患者中分泌的模块化结合蛋白2 (SMOC2) 水平与疾病严重程度和医院再入院风险相关. 较高的SMOC2表明再接收的可能性更大,表明其作为预测生物标志物的潜力.